An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life

Completed

Conditions studied: Psoriasis Vulgaris

In brief

The purpose of this study is to document quality of life, patient satisfaction, effect on itching, and control of psoriasis vulgaris associated with use of calcipotriene/betamethasone dipropionate (Taclonex®) topical suspension 0.005% / 0.064% for treatment of plaque psoriasis under real-life conditions.

Key facts

Study ID

NCT01982552

Run by

LEO Pharma

People needed

147

Starts

2013-07-01

Expected to finish

2014-01-01

Last updated by the study team

2018-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed and dated informed consent obtained prior to any study related activities
• Aged 18 years or above
• Either sex
• Any race or ethnicity
• Attending a hospital outpatient clinic or the private practice of a board-certified dermatologist, dermatology-certified nurse practitioner or physician assistant trained in dermatology
• Clinical diagnosis of psoriasis vulgaris involving scalp and/or body amenable to treatment with a maximum of 100 g of topical medication per week.
• Patients who receive a prescription of calcipotriene/betamethasone dipropionate (Taclonex®) topical suspension 0.005% / 0.064% as per an investigator's clinical judgment and in accordance with the US label, and who have access to the medication
• Able to communicate with the investigator, read and understand English, and understand and comply with the requirements of the study

You may not qualify if…

• Prior treatment with calcipotriene/betamethasone dipropionate (Taclonex®) topical suspension, 0.005%/0.064%.
• Contraindications or any warnings/precautions according to the US label.
• Current participation in any other interventional clinical study.
• Females who are pregnant, breast-feeding, or females of child-bearing potential wishing to become pregnant during the study.

Where it is running

• Alliance Dermatology and Mohs Center — Phoenix, Arizona, United States
• Center for Dermatology Clinical Research — Fremont, California, United States
• Academic Alliance Dermatology — Clearwater, Florida, United States
• Dermatology Associates and Research — Coral Gables, Florida, United States
• Melissa Knuckles Dermatology — Corbin, Kentucky, United States
• Grekin Skin Institute — Warren, Michigan, United States
• Bettencourt Skin Center — Henderson, Nevada, United States
• Las Vegas Skin and Cancer Clinic — Las Vegas, Nevada, United States
• Psoriasis Treatment Center of Central NJ — East Windsor, New Jersey, United States
• Skin Specialty Dermatology — New York, New York, United States
• Center for Clinical Studies — Webster, Texas, United States
• West End Dermatology — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.